Methylprednisolone intravenously 1 day after surgery has sustained analgesic and opioid-sparing effects

Acta Anaesthesiologica Scandinavica

Volumn 48, Issue 10, 2004, Pages 1223-1231

  Romundstad, Luis ^a   Breivik, H ^a   Niemi, G ^a   Helle, A ^a   Stubhaug, A ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Analgesia; Glucocorticoid; Ketorolac; Methylprednisolone; Opioid sparing effect; Orthopaedic surgery; Postoperative pain

Indexed keywords

BUPIVACAINE; FENTANYL; KETOBEMIDONE; KETOROLAC; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; PLACEBO;

ADULT; ANALGESIA; ANALGESIC ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG USE; EPIDURAL ANESTHESIA; FATIGUE; FEMALE; FLUSHING; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORTHOPEDIC SURGERY; PAIN ASSESSMENT; POSTOPERATIVE INFLAMMATION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VISUAL ANALOG SCALE; VOMITING;

ADOLESCENT; ADULT; AGED; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; KETOROLAC; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PAIN MEASUREMENT; PAIN, POSTOPERATIVE;

EID: 8544270106     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2004.00480.x     Document Type: Article

References (26)

1. Skjelbred P, Løkken P. Reduction of pain and swelling by a corticosteroid. Eur J Clin Pharmacol 1982; 21: 391-6.
2. Holte K, Kehlet H. Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications. J Am Coll Surg 2002; 195: 694-712.
3. Bisgaard T, Klarskov B, Kehlet H, Rosenberg J. Preoperative dexamethasone improves surgical outcome after laparoscopic cholecystectomy. A randomized doubleblind placebo-controlled trial. Ann Surg 2003; 238: 651-60.
4. Schleimer RP. An overview of glucocorticoid anti-inflammatory actions. Eur J Clin Pharmacol 1993; 45 (Suppl. 1): S3-7; discussion S43-4.
5. Ferreira SH, Cunha FQ, Lorenzetti FB et al. Role of lipocortin-1 in the anti-hyperalgesic actions of dexamethasone. Br J Pharmacol 1997; 121: 883-8.
6. Warncke T. Neurophysiological Studies of Peripheral and Central Mechanisms of Primary and Secondary Hyperalgesia. Thesis for DMSc degree, University of Oslo, Norway 2001: 24-7.
7. Falkenstein E, Tillmann HC, Christ M, Feuring M, Wehling M. Multiple actions of steroid hormones - a focus on rapid, nongenomic effects. Pharmacol Rev 2000; 52: 513-56.
8. Sauerland S, Nagelschmidt M, Mallmann P, Neugebeuer EA. Risks and benefits of preoperative high dose methylprednisolone in surgical patients: a systematic review. Drug Saf 2000; 23: 449-61.
9. Gilron I, Milne B, Hong M. Cyclooxygenase-2 inhibitors in postoperative pain management. Current evidence and future directions. Anesthesiology 2003; 99: 1198-208.
10. Høgevold HE, Lyberg T, Kahler H, Haug E, Reikeras O. Changes in plasma IL-1beta, TNF-11alpha, IL-6 after total hip replacement surgery in general or regional anaesthesia. Cytokine 2000; 12: 1156-9.
11. Zhou TJ, Tang J, White PF. Propacetamol versus ketorolac for treatment of acute postoperative pain after total hip or knee replacement. Anesth Analg 2001; 92: 1569-75.
12. Stubhaug A, Breivik H. Post-operative analgesic trials: some important issues. Bailliere's Clin Anaesthesiol Int Prac Research 1995; 9: 555-84.
13. Moher D, Schulz KF, Altman DG, The Consort Statement. Revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001; 357: 1191-4.
14. Meinert CL. Clinical trials. in: Meinert CL, ed. Design, Conduct and Analysis. Oxford: Oxford University Press, 1986: 97-9.
15. Moore A, Mcquay H, Gavaghan D. Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics. Pain 1996; 66: 229-37.
16. Mathews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. Br Med J 1990; 300: 230-5.
17. Laska EM, Siegel C, Sunshine A. Onset and duration: measurement and analysis. Clin Pharmacol Ther 1991; 49: 1-5.
18. Stubhaug A, Grimstad J, Breivik H. Lack of analgesic effect of 50 and 100 mg oral tramadol after orthopaedic surgery: a randomized, double-blind, placebo and standard active drug comparison. Pain 1995; 62: 111-8.
19. Cepeda MS, Africano JM, Polo R, Alcala R, Carr DB. What decline in pain intensity is meaningful to patients with acute pain? Pain 2003; 105: 151-7.
20. Bjune K, Stubhaug A, Dodgson M, Breivik H. Additive analgesic effect of codeine and paracetamol can be detected in strong but not moderate pain after Caesarean section. Baseline pain-intensity is a determinant of assay-sensitivity in a postoperative analgesic trial. Acta Anaesthesiol Scand 1996; 40: 399-407.
21. Breivik EK, Bjørnsson GA. Variation of surgical trauma and baseline pain intensity: effects on assay senstitivity of an analgesic trial. Eur J Oral Sci 1998; 106: 844-52.
22. Benedetti F, Polio A, Lopiano L. et al. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci 2003; 23: 4315-23.
23. Moscucci M, Byrne L, Weintraub M, Cox C. Blinding, unblinding, and the placebo effect, an analysis of patients' guesses of treatment assignment in a double-blind clinical trial. Clin Pharmacol Ther 1987; 41: 259-65.
24. Beecher HK. The powerful placebo. J Am Med Assoc 1955; 159: 1602-6.
25. Mcquay HJ, Moore A. An Evidence-Based Resource for Pain Relief. Oxford: Oxford University Press, 1998: 20-31.
26. Smith LA, Carroll D, Edwards JE, Moore RA, Mcquay HJ. Single-dose ketorolac and pethidine in acute postoperative pain: systematic review with meta-analysis. Br J Anaesth 2000; 84: 48-58.